Palisade Bio Inc.
Organization details
- Legal name
- Palisade Bio Inc.
- Former names
- Seneca Biopharma, Inc. Neuralstem, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Carlsbad
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PALI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001357459
- EIN
- 52-2007292
Board of directors
-
Binxian Wei · DirectorSince 2023
-
Cristina Csimma · DirectorSince 2023
-
Donald Allen Williams · DirectorSince 2023
-
Emil Chuang · DirectorSince 2025
-
James R. Neal · DirectorSince 2023
-
John David Finley · Director · CEO CFOSince 2023
-
Jordan Michael Zwick · DirectorSince 2026
-
Margery B. Fischbein · DirectorSince 2024
-
Mary Ann Gray · DirectorSince 2023
-
Robert Baltera Jr. · DirectorSince 2026
-
Robert J. Trenschel · DirectorSince 2023
-
Stephanie Diaz · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
72.5%
-
91.4%
-
99.7%
Board connections
2 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
Akari Therapeutics plc Same sectorvia James R. Neal
-
Compass Therapeutics Inc. Same sectorvia Mary Ann Gray
-
Keros Therapeutics Inc. Same sectorvia Mary Ann Gray
-
Processa Pharmaceuticals Inc. Same sectorvia James R. Neal
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $296,650
- 10 purchases by 2 insiders
- Sold, last 12 months
- $420,525
- 4 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 19, 2026 | Capers Julien E. Officer (See Remarks) | Grant or award | +787,300 | — | — |
| Oct 6, 2026 | John David Finley Director, Officer (CEO CFO) | Option exercise | +3,227,384 | — | — |
| Oct 6, 2026 | Jones Mitchell Lawrence Officer (See Remarks) | Option exercise | +2,620,850 | — | — |
| Oct 6, 2026 | John David Finley Director, Officer (CEO CFO) | Shares withheld for tax | −1,411,982 | $1.49 | $2,103,853 |
| Oct 6, 2026 | Jones Mitchell Lawrence Officer (See Remarks) | Shares withheld for tax | −1,031,102 | $1.49 | $1,536,342 |
| Oct 2, 2026 | Donald Allen Williams Director | Open-market purchase | +10,000 | $1.46 | $14,600 |
| Oct 1, 2026 | Donald Allen Williams Director | Open-market purchase | +10,000 | $1.42 | $14,200 |
| Aug 19, 2026 | John David Finley Director, Officer (CEO, CFO) | Gift | −88,400 | — | — |
| Aug 19, 2026 | John David Finley Director, Officer (CEO, CFO) | Gift | +88,400 | — | — |
| Jul 9, 2026 | Robert Baltera Jr. Director | Open-market purchase | +25,000 | $1.96 | $49,000 |
| Jul 8, 2026 | Robert Baltera Jr. Director | Open-market purchase | +20,000 | $1.99 | $39,800 |
| Jul 7, 2026 | Robert Baltera Jr. Director | Open-market purchase | +30,000 | $2.03 | $60,900 |
| Jul 7, 2026 | John David Finley Director, Officer (CEO, CFO) | Open-market sale | −146,798 | $2.07 | $303,872 |
| Jul 7, 2026 | Jones Mitchell Lawrence Officer (Chief Medical Officer) | Open-market sale | −51,880 | $2.05 | $106,354 |
| Jul 7, 2026 | John David Finley Director, Officer (CEO, CFO) | Option exercise | +133 | $0.70 | $93 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Palisade Bio Inc.
Who is the CEO of Palisade Bio Inc.?
John David Finley is Palisade Bio Inc.'s CEO, CFO, Director.
How many directors are on Palisade Bio Inc.'s board?
Palisade Bio Inc.'s board has 12 directors: Binxian Wei, Cristina Csimma, Donald Allen Williams, Emil Chuang, James R. Neal, John David Finley, Jordan Michael Zwick, Margery B. Fischbein, Mary Ann Gray, Robert Baltera Jr. and 2 others.
Are Palisade Bio Inc. insiders buying or selling shares?
Over the last 12 months, Palisade Bio Inc. insiders bought $296,650 of shares in 10 purchases and sold $420,525 of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="palisade-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.